Concepedia

Fred Harbinski

FH

17

Publications

1.9K

Citations

15

H-Index

2004

Active since

Affiliations

Novartis (Switzerland)(Current)

Harvard University

Brigham and Women's Hospital

Novartis Institutes for BioMedical Research

Pathways Behavioral Services

Fred Harbinski is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicineCell BiologyPharmacologyDrug DiscoverySystems BiologyBiochemistryTumor BiologyCancer ResearchNatural SciencesMolecular Biology

Publications per year

2004–2022

17

Publications

17

Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

William E. Dowdle, Beat Nyfeler, Jane Nagel et al. · Nature Cell Biology · 2014 · 715 citations

Inflammation, Cell Autophagy, Signal Transduction +13

TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A

X. Rosa, Mercedes Prudencio, Yuka Koike et al. · Nature · 2022 · 520 citations · Full text

Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer target

Ting Chen, Duygu Özel, Yuan Qiao et al. · Nature Chemical Biology · 2011 · 115 citations · Full text

Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth

Fred Harbinski, Vanessa J. Craig, Sneha Sanghavi et al. · Cancer Discovery · 2012 · 107 citations

Drug Target, Rescue Screens, Kinase Inhibitors +18

Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39

Frédéric Bassilana, Adam Carlson, Jennifer DaSilva et al. · Nature Chemical Biology · 2014 · 66 citations

Signal Transduction, Receptor Gpr39, Signaling Pathway +10

Rows per page

1–5 of 17